BioCardia, Inc(NASDAQ:BCDA) 
BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapeutics for cardiovascular diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and ALLOGENEIC cell therapy for cardiac and pulmo...
Website: http://www.biocardia.com/
Full Time Employees: 20
CEO: Peter Altman
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 2.15
H 2.15
L 1.96
C 2.01
V 48,404
10EMA 2.01
20EMA 2.01
60EMA 2.01
120EMA 2.01
250EMA 2.01